Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Epizyme Inc (NASDAQ:EPZM)

9.50
Delayed Data
As of May 04
 -0.375 / -3.80%
Today’s Change
8.27
Today|||52-Week Range
28.48
-40.70%
Year-to-Date

Today’s Trading

Previous close9.88
Today’s open9.65
Day’s range9.09 - 9.68
Volume579,289
Average volume (3 months)544,344
Market cap$565.0M
Dividend yield--
Data as of 3:59pm ET, 05/04/2016

Growth & Valuation

Earnings growth (last year)-98.80%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-93.82%
P/E ratioNM
Price/Sales249.31
Price/Book2.43

Competitors

 Today’s
change
Today’s
% change
AMPHAmphastar Pharmaceut...-0.32-2.61%
PDLIPDL BioPharma Inc-0.27-7.58%
AIMTAimmune Therapeutics...-0.01-0.08%
CLVSClovis Oncology Inc-0.76-5.45%
Data as of 3:59pm ET, 05/04/2016

Financials

Next reporting dateMay 9, 2016
EPS forecast (this quarter)-$0.50
Annual revenue (last year)$2.6M
Annual profit (last year)-$132.4M
Net profit margin-5,170.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert B. Bazemore
CFO, Treasurer &
EVP-Finance & Administration
Andrew E. Singer
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs